FDA Inspection
Voyant Beauty, Inc.Voyant Beauty, Inc. – FDA Inspection, May 30, 2025
Record Details
This FDA Inspection record concerns Voyant Beauty, Inc., with an inspection on May 30, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · e4ce7d1c-b7fd-40a8-9ff1-57090f4d9063
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1264006
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.84(a)Components withheld from use pending release
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.100(a)Absence of Written Procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Voyant Beauty, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| October 25, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 8, 2017 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| December 16, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 30, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 13, 2014 | VAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
Other documents for Voyant Beauty, Inc.
- FDA Inspection 1115545 - 2019-10-25
- FDA Inspection 1028777 - 2017-06-08
- FDA Inspection 999713 - 2016-12-16
- FDA Inspection 880974 - 2014-05-30
- FDA Inspection 874562 - 2014-03-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.